More than 20 years of experience in the global healthcare industry

Founder, Chairman, CEO Micromed Labs, Oculus Innovative, Ruthigen, Inc.

IPO experience, including raising $170M in capital

Multiple FDA and CE approvals of drugs and devices, and regulatory readiness.

36 patents in areas of anti-infective and medical devices.

Executive Vice President, Sales and Business Development

Investment Banker completed over $400M in transactions

Director of National Investment Bankers Association

Extensive experience in the pharmaceutical industry, research and development for marketed and in development products, global Regulatory affairs and clinical research.

Has held positions in industry as Director of Clinical Operations at Artemis, Director of Regulatory Affairs at Merck Serono, Head of International Labeling Operation at Boehringer Ingelheim and Therapeutic Lead in oncology at Abbott.

Extensive scientific, drug development and regulatory experience.

Earned a Ph.D. in healthcare administration, MS in clinical laboratory sciences, and two bachelor degrees in biology and chemistry.

Served as Chief Financial Officer of Ruthigen, Inc.

Buy-side and Sell-side equity research analyst covering medical devices and diagnostics sectors with Symmetry Capital, Needham & Co., and ThinkEquity

Held research positions at Guidant (now Abbott Laboratories) and Synteni (acquired by Incyte Corporation)